← Open Payments lookup

NICOMEDES SANSAIT: Open Payments

NPI 1619063120 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,883 in 142 payments from 13 companies in 2025. Trend: 2023 $578 · 2024 $1,627 · 2025 $1,883

Food & beverage: $1,883
CompanyPaymentsAmount
ABBVIE INC.49$332
E.R. Squibb & Sons, L.L.C.20$270
Otsuka America Pharmaceutical, Inc.14$242
Vanda Pharmaceuticals Inc.12$231
Teva Pharmaceuticals USA, Inc.13$193
Neurocrine BioSciences, Inc.13$183
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$148
Axsome Therapeutics, Inc.3$71
Alkermes, Inc.3$62
Takeda Pharmaceuticals U.S.A., Inc.3$62

Products named: VRAYLAR, COBENFY, UZEDY, INGREZZA, CAPLYTA, REXULTI, HETLIOZ, FANAPT.

Industry payments across OH — which companies pay providers there.